Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% dextrose epidural injections for chronic low back pain
IRCT20201028049175N5Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dextrose and bupivacaine in chronic low back pain (CLBP) (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Patients pain score. Started Apr 2021; status: completed.
02
Drugs
dextrosebupivacaine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on IRCT20201028049175N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049175N5.